Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -53.31% is 72% above its 5-year average of -190.75%, near the high end of its 5-year range (-541.94%–-18.21%).
55.24% below its 12-month average of -34.34%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -14.63%.
RETURN ON ASSETS (ROA)
-53.31%
RETURN ON ASSETS (ROA) AVG TTM
-34.34%
RETURN ON ASSETS (ROA) AVG 3Y
-114.79%
RETURN ON ASSETS (ROA) AVG 5Y
-190.75%
RETURN ON ASSETS (ROA) AVG 10Y
-147.67%
RETURN ON ASSETS (ROA) AVG 15Y
-117.89%
RETURN ON ASSETS (ROA) AVG 20Y
-133.44%
CURRENT VS TTM AVG
-55.24%
CURRENT VS 3Y AVG
+53.56%
CURRENT VS 5Y AVG
+72.05%
CURRENT VS 10Y AVG
+63.90%
CURRENT VS 15Y AVG
+54.78%
CURRENT VS 20Y AVG
+60.05%
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-65.23%
vs the sector median at left
Tenax Therapeutics, Inc.
Market Cap
$51.19M
Return on Assets (ROA)
-53.31%
TTM Avg
-34.34%
3Y Avg
-114.79%
5Y Avg
-190.75%
Market Cap
$51.23M
Return on Assets (ROA)
-127.67%
TTM Avg
-99.17%
3Y Avg
-76.90%
5Y Avg
-71.83%
Market Cap
$51.12M
Return on Assets (ROA)
-44.77%
TTM Avg
-25.55%
3Y Avg
-81.14%
5Y Avg
-76.43%
Market Cap
$51.88M
Return on Assets (ROA)
-34.52%
TTM Avg
-27.74%
3Y Avg
-32.72%
5Y Avg
-28.49%
Market Cap
$51.99M
Return on Assets (ROA)
N/A
TTM Avg
-109.69%
3Y Avg
-346.56%
5Y Avg
-277.44%
Market Cap
$50.28M
Return on Assets (ROA)
5.76%
TTM Avg
13.86%
3Y Avg
7.25%
5Y Avg
29.75%
Market Cap
$50.27M
Return on Assets (ROA)
-97.71%
TTM Avg
-228.91%
3Y Avg
-360.64%
5Y Avg
-295.62%
Market Cap
$52.60M
Return on Assets (ROA)
-15.99%
TTM Avg
-6.85%
3Y Avg
0.40%
5Y Avg
2.07%
Market Cap
$49.71M
Return on Assets (ROA)
-68.60%
TTM Avg
-124.17%
3Y Avg
-83.59%
5Y Avg
-65.75%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tenax Therapeutics, Inc. (TENX) | $51.19M | -53.31% | -34.34% | -114.79% | -190.75% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | -127.67% | -99.17% | -76.90% | -71.83% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | -44.77% | -25.55% | -81.14% | -76.43% |
| ImageneBio Inc (IMA)vs › | $51.88M | -34.52% | -27.74% | -32.72% | -28.49% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | N/A | -109.69% | -346.56% | -277.44% |
| biote Corp. (BTMD)vs › | $50.28M | 5.76% | 13.86% | 7.25% | 29.75% |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | -97.71% | -228.91% | -360.64% | -295.62% |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | -15.99% | -6.85% | 0.40% | 2.07% |
| INmune Bio, Inc. (INMB)vs › | $49.71M | -68.60% | -124.17% | -83.59% | -65.75% |
| Spectral AI, Inc. (MDAI)vs › | $52.83M | -54.01% | -81.00% | -93.15% | -65.68% |
ROA
-53.3%
ROE
-57.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -50.47% |
| 2024-12-31 | -18.21% |
| 2023-12-31 | -65.99% |
| 2022-12-31 | -324.49% |
| 2021-12-31 | -541.94% |
| 2020-12-31 | -143.42% |
| 2019-12-31 | -131.88% |
| 2018-12-31 | -51.09% |
| 2017-12-31 | -89.37% |
| 2016-12-31 | -188.19% |
| 2015-12-31 | -19.29% |
| 2015-04-30 | -16.34% |
| 2013-04-30 | -57.58% |
| 2012-04-30 | -227.33% |
| 2011-04-30 | -266.75% |
| 2010-04-30 | -296.06% |
| 2009-04-30 | -208.96% |
| 2008-04-30 | -80.06% |
| 2007-04-30 | -166.42% |
| 2006-04-30 | -545.34% |
| 2005-04-30 | -211.73% |
| 2004-04-30 | -124.30% |
| 2003-04-30 | -149.89% |
| 2002-04-30 | -264.75% |
| 2001-04-30 | -44.09% |
| 2000-04-30 | -26.97% |
| 1999-04-30 | -182.27% |
| 1998-04-30 | -81.14% |
| 1997-04-30 | -600.44% |
| 1996-04-30 | -595.58% |
